Cite
Chute DF, Zhao S, Strohbehn IA, et al. Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors. Am J Kidney Dis. 2021;doi: 10.1053/j.ajkd.2021.05.012.
Chute, D. F., Zhao, S., Strohbehn, I. A., Rusibamayila, N., Seethapathy, H., Lee, M., Zubiri, L., Gupta, S., Leaf, D. E., Rahma, O., Drobni, Z. D., Neilan, T. G., Reynolds, K. L., & Sise, M. E. (2021). Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors. American journal of kidney diseases : the official journal of the National Kidney Foundation, . https://doi.org/10.1053/j.ajkd.2021.05.012
Chute, Donald F, et al. "Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors." American journal of kidney diseases : the official journal of the National Kidney Foundation vol. (2021). doi: https://doi.org/10.1053/j.ajkd.2021.05.012
Chute DF, Zhao S, Strohbehn IA, Rusibamayila N, Seethapathy H, Lee M, Zubiri L, Gupta S, Leaf DE, Rahma O, Drobni ZD, Neilan TG, Reynolds KL, Sise ME. Incidence and Predictors of CKD and Estimated GFR Decline in Patients Receiving Immune Checkpoint Inhibitors. Am J Kidney Dis. 2021 Jun 24; doi: 10.1053/j.ajkd.2021.05.012. Epub 2021 Jun 24. PMID: 34174363.
Copy
Download .nbib